Who invested in Tyra Biosciences

2 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 2 months ago

Funding summaryUpdated 26 Oct 2026

$600Mraised across 2 rounds since 2024, from 2 sources

$200MRound$400MRound

Latest round: Round, $400MSept 2026
Step-upi: 2×
Investors: 8

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

202420252026

$200MRound$400MRound

First round: Round, $200M
Biggest round: $400M
Between rounds: 2.6 years

The rounds

Sept 2026
Round$400M3 new3 returning
Source recorded
Feb 2024
Round$200M5 new
Source recordedSEC filing: $200M sold, first sale Feb 2024

Founders and team

From Tyra Biosciences's own website and the SEC filings it signed: 18 on the team.

Todd HarrisChief Executive Officer
Bhavesh AsharChief Operating Officer
Heather FauldsChief Regulatory Officer
Liz PaganoChief Human Resources Officer
Piyush PatelChief Development Officer
Robert L. HudkinsChief Technology Officer
Ronald V. SwansonChief Scientific Officer
Alan FuhrmanChief Financial Officer
Daniel BensenChief Discovery Officer
Adele GulfoBoard Member
Habib DableBoard Member
Kelleen CheaOffice Manager
S. Michael RothenbergBoard Member
Susan MoranBoard member
Hiroomi TadaExecutive Officeri
Jake SimsonBoard Member
Melissa McCrackenBoard Member
Rehan VerjeeBoard Member

On the board, as filediGilla KaplanIsan ChenNina KjellsonRobert MoreSid Subramony

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Round2024Round2026

RA Capital Management

Janus Henderson Investors

Cormorant Asset Management

Everyone who backed them

RA Capital ManagementPrivate equity2rounds

Janus Henderson InvestorsPrivate equity2rounds

Cormorant Asset ManagementPrivate equity2rounds

CanaanVC firm1round

OrbiMedPrivate equity1round

InvusPrivate equity1round

TCGPrivate equity1round

TCG CrossoverVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Tyra Biosciences as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Nextech InvestPrivate equityPer its own site

Quick answers about Tyra Biosciences

Who invested in Tyra Biosciences?

Tyra Biosciences's investors include RA Capital Management, Janus Henderson Investors, Cormorant Asset Management, Canaan and OrbiMed, and 3 more on record.